Satsuma Pharmaceuticals

+$0.14 (+2.81%) Today
+$0.47 (+9.16%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STSA and other ETFs, options, and stocks.

About STSA

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine.

CEO
John A. Kollins
Employees
19
Headquarters
San Francisco, California
Founded
2016

STSA Key Statistics

Market Cap
161.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
129.50K
High Today
$5.14
Low Today
$5.00
Open Price
$5.00
Volume
196.80K
52 Week High
$7.48
52 Week Low
$3.50

STSA Earnings

-$0.77
-$0.51
-$0.26
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure